Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
Ten reasons why DHBs need to act to control prescription pricing
+Print Archive
In print
NEWS
Ten reasons why DHBs need to act to control prescription pricing
Thursday 1 February 2018, 12:00 PM

With Chemist Warehouse bursting onto the scene late last year offering zero prescription fees, prescription pricing has again become a topic of conversation. After working as a pharmacy wholesaler for 10 years, and in health in general for 35 years, pharmacy sector observer Anna Mickell has a few ideas on what works and what doesn’t. She gives her opinion on why prescription prices need to be controlled by DHBs
Despite a few left-leaning tendencies, I support a market approach when it comes to matters of health.
I think the Government and its agents need t
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.